MedPath

ALIMERA SCIENCES INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$304M
Website

Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema

Phase 3
Completed
Conditions
Diabetic Macular Edema
Interventions
First Posted Date
2007-06-25
Last Posted Date
2014-02-13
Lead Sponsor
Alimera Sciences
Target Recruit Count
37
Registration Number
NCT00490815
Locations
🇺🇸

John Hopkins University, Baltimore, Maryland, United States

Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema

Phase 3
Completed
Conditions
Diabetic Macular Edema
Interventions
Procedure: Standard of care laser photocoagulation
Drug: Fluocinolone Acetonide
First Posted Date
2006-06-27
Last Posted Date
2014-05-07
Lead Sponsor
Alimera Sciences
Target Recruit Count
956
Registration Number
NCT00344968
© Copyright 2025. All Rights Reserved by MedPath